Aptameric nanobiosensors for the diagnosis of COVID-19: An update.
Mater Lett
; 308: 131237, 2022 Feb 01.
Article
in English
| MEDLINE | ID: covidwho-1560920
ABSTRACT
COVID-19 pandemic has left a catastrophic effect on the world economy and human civilization. As an effective step towards controlling the transmission of viral infections during multiple waves of COVID-19, there is an urgent need to develop robust nanobiosensors for the detection of SARS-CoV-2 with high sensitivity, specificity, and fast analysis. Aptameric nanobiosensors are rapid and sensitive diagnostic platforms, capable of SARS-CoV-2 detection, which overcomes the limitations of the conventional techniques. This review article presents an outline of the aptameric nanobiosensors established for improved diagnosis of SARS-CoV-2 and the future perspectives are also covered.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Diagnostic study
Language:
English
Journal:
Mater Lett
Year:
2022
Document Type:
Article
Affiliation country:
J.matlet.2021.131237
Similar
MEDLINE
...
LILACS
LIS